Kidney Allograft Dysfunction Without Reversible Causes — KADWORC  

Kidney Graft Dysfunction Clinical Trial

Official title: A Randomized Controlled Trial of Reducing Calcineruin Inhibitor Target Level by 50% Versus Converting to Rapamycin in Chronic Kidney Dysfunction Without Reversible Causes

Status Withdrawn

Clinical Trial Summary

The purpose of this study is to learn the best way to prolong kidney life in patients exposed to calcineurin inhibitors, who already have evidence of damage possibly caused by the calcineurin inhibitor on kidney biopsy.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Kidney Graft Dysfunction

• NCT number: NCT01492894
• Study type: Interventional
• Source: University of Minnesota - Clinical and Translational Science Institute
• Status: Withdrawn
• Phase: Phase 4
• Start date: January 2008
• Completion date: October 2011